| abstract |
Inhibitors of HBV replication of formula (I) n nincluding stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R 1 to R 7 have the meaning as defined herein.n n The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy. |